Clinical Trials Logo

Concentration Ability Impaired clinical trials

View clinical trials related to Concentration Ability Impaired.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06208943 Recruiting - COVID-19 Clinical Trials

Neural and Cognitive Consequences of COVID-19 Survival

Start date: October 1, 2021
Phase:
Study type: Observational

The novel coronavirus SARS-CoV-2 infection, COVID, continues to rage throughout the world with 115,000,000 confirmed cases and over 2,500,000 deaths (as of Mar 3, 2021). This translates to millions of people surviving COVID19 infection. While the lungs are ground zero, COVID tears through organ systems from brain to blood vessels. We are now beginning to see people recover but complain of ongoing problems, including lingering cognitive problems, depression, and anxiety. We have brought together 2 laboratories with complementary techniques including psychological testing and neuroimaging methods togethers with markers in the blood that may signal damage in the brain. A close look at these problems is timely and imperative if we are to understand the pathophysiology of 'COVID brain' and prepare for downstream problems.

NCT ID: NCT05911737 Recruiting - Clinical trials for Concentration Ability Impaired

Ocular Parameters in Patients With Sleep Apnea

Start date: July 1, 2022
Phase:
Study type: Observational

The aim of this study is to assess the ocular parameters of drowsiness in patients with diagnosed Obstructive Sleep Apnea Syndrome through objective methods of ocular imaging and subjective evaluation methods (questionnaire)